Zogenix Adds $20 Million

Zogenix Inc., a San Diego-based drug company focused on pain management and CNS disorders, has raised $20 million in new Series B funding from Chicago Growth Partners. This brings the round total to $71 million, with other investors including Clarus Ventures, Domain Associates,Scale Venture Partners, Thomas, McNerney & Partners, Oxford Finance Corp. and Abingworth Management.

North AmericaUSBriefs